Parent, Robert, Normand Leblanc, and Michel Lavallée. Nitroglycerin reduces myocardial oxygen consumption during exercise despite vascular tolerance. Am J Physiol Heart Circ Physiol 290: H1226 -H1234, 2006. First published November 4, 2005 doi:10.1152/ajpheart.00607.2005.-The long-term benefits of nitroglycerin (NTG) therapy are limited by the development of vascular tolerance and endothelial dysfunction in conductance coronary arteries. We have determined whether nitrate tolerance extends to NTG effects on myocardial O2 consumption (MV O2) and the ability of endogenous nitric oxide (NO) to modulate MV O2 during exercise. In chronically instrumented dogs (n ϭ 8), hemodynamic and MV O2 responses to treadmill exercise were measured before, during tolerance (3 and 7 days of NTG delivery), and 7 days after NTG withdrawal. Acute NTG delivery caused a parallel downward shift of the MV O2-triple product (TP) relations and reversed the disproportionate increases in MV O 2 caused by the blockade of NO formation. After 7 days of continuous transdermal NTG delivery, vascular tolerance was displayed as a Ͼ75% reduction of coronary blood flow (CBF) responses to NTG boluses. Despite vascular nitrate tolerance, MV O2-TP relations were shifted downward compared with pre-NTG exercise. Seven days after NTG withdrawal, vascular responses to boluses of NTG had recovered from tolerance, and MV O2-TP relations during exercise were back to pre-NTG level. At that time, blockade of NO formation failed to alter MV O2-TP relations. Thus NTG caused a sustained reduction of cardiac MV O2, independent of metabolic demand during exercise, despite tolerance of the coronary microcirculation. NTG-induced vascular tolerance and MV O2 reductions were reversible by NTG withdrawal, but endogenous NOdependent modulation of O 2 consumption was severely impaired.
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nitrates; exercise; nitric oxide NITROGLYCERIN (NTG) has been used over a century to alleviate myocardial ischemia and anginal pain. The clinical benefits of organic nitrate therapy are the consequence of a better match between myocardial O 2 supply/demand balance. The oxygensparing effect of NTG results from a reduced cardiac metabolic demand (decreased ventricular loading), whereas the potent and long-lasting vasodilator effects on conductance coronary vessels ensure an augmented O 2 supply (1). The salutary effects of nitrate therapy are, however, limited in time by the development of vascular tolerance. Several mechanisms are currently considered important in the development of tolerance: mechanism-based processes involving impaired bioconversion of NTG into its active metabolite(s) (4, 28) ; neurohormonal responses (pseudotolerance) counteracting the primary dilator effects of NTG (8, 23) ; and production of O 2 -derived free radicals scavenging nitric oxide (NO), presumably the key intermediate of NTG effects (15, 20, 22) . This increased oxidative stress also limits endogenous NO bioavailability and causes endothelial dysfunction displayed as impaired endothelium-dependent vascular responses (10 -12, 16, 21, 26, 31) .
Aside from its vascular effects, NTG may also spare O 2 by directly decreasing tissue metabolism through a cGMP-independent process (30) . This feature of NTG is shared by endothelium-dependent dilators (carbachol and bradykinin) and is lost in transgenic endothelial NO synthase (eNOS)Ϫ/Ϫ mice (2, 9, 17, 18, 27, 33) . Thus the decrease in myocardial O 2 consumption (MV O 2 ) triggered by NTG may be causally related to the production of NO. The physiological importance of NO-dependent modulation of cardiac MV O 2 is highlighted by the dramatic increase in O 2 consumption during exercise performed after NO formation blockade with N -nitro-L-arginine (L-NNA) (3) .
Nitrate tolerance has mainly been considered as a vascular phenomenon with little attention paid to the effects of chronic NTG exposure on cardiac MV O 2 . The consequences of nitrate tolerance may differ in vascular and myocardial tissues. NTG has been reported to provide sustained cardioprotective effects and not to increase myocardial oxidative stress, despite vascular tolerance (6, 7) . The present study addresses the following issues: 1) Can NTG act as a surrogate of NO in influencing cardiac MV O 2 after the acute blockade of endogenous NO formation? 2) In the setting of vascular tolerance, can NTG reduce cardiac MV O 2 ? 3) Does chronic exposure to NTG alter the ability of endogenous NO to modulate cardiac MV O 2 ?
METHODS
Experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Montreal Heart Institute (University of Montreal).
Instrumentation. After general anesthesia with pentobarbital sodium (30 mg/kg iv), eight mongrel dogs (31 Ϯ 1 kg) underwent a left thoracotomy to implant an aortic catheter used to measure arterial pressure with an external transducer (model 800, Bentley Trantec). A solid-state pressure gauge (model P6.5, Konigsberg Instruments) was inserted in the left ventricular (LV) cavity to record LV pressure (LVP) and to obtain its first derivative over time (LV dP/dt). The miniature pressure gauge was cross-calibrated against LVP measured with a chronically implanted LV catheter. A pulmonary artery catheter was implanted and used for systemic drug delivery. A cardiotachometer (model 9857, Sensor Medics) triggered by LVP was used to monitor heart rate (HR). Coronary blood flow (CBF) was measured with a Doppler transducer placed around the proximal circumflex coronary artery and a 10-MHz-pulsed Doppler flowmeter (C. J. Hartley). A Silastic (Dow Corning) catheter was implanted in the coronary sinus (CS). Postoperatively, analgesia was provided with buprenorphine (0.3 mg im, Reckitt and Colman Pharmaceuticals), and procaine penicillin G (300,000 U im) and benzathine penicillin G (300,000 U im) were administered prophylactically for 10 days. Hemodynamic variables were continuously recorded on a VHS tape using a PCM recording adaptor (model 4000A, Vetter) and monitored on a direct ink-writing stripchart recorder (model 2800s, Gould). Mean arterial pressure (MAP) and mean CBF were obtained with active filters with a time constant of 2 s.
Protocols. Experiments were initiated 3-5 wk after surgery in conscious healthy dogs. In dogs lying quietly on a table, CBF responses to systemic boluses of 1.0, 3.0, and 10.0 g/kg of nitroglycerin (Sabex) were measured. At least 2 h after the completion of NTG boluses, animals performed a standard treadmill exercise consisting of three steps lasting 4 min: 3 mph, 0% grade; 4 mph, 5% grade; and 6 mph, 10% grade. Blood samples from the aortic and CS catheters were collected in lightly heparinized syringes while the dogs were standing quietly on the treadmill and 3 min after the beginning of each step of exercise, when a steady state was reached. Samples were immediately processed to measure hemoglobin concentration ([Hb]) and Hb O 2 saturation with a cooxymeter (OSM-2, Radiometer). A Stat Profile pHOx Analyzer (Nova Biomedical) was used to measure PO 2. This exercise protocol was repeated 30 min after the beginning of a systemic infusion of NTG (2.0 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ), which was maintained throughout exercise. On a different day and after a control exercise protocol, 35 mg/kg of L-NNA (Sigma) was administered over 10 min. Exercise was performed 30 min after the completion of L-NNA delivery. NTG (2.0 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was then infused for 30 min and the exercise protocol repeated. On the basis of preliminary experiments (n ϭ 5), a 5-day recovery period after L-NNA allowed exercise-induced responses and MV O2-TP relations to return to control levels. Consequently, continuous NTG delivery to achieve NTG tolerance was initiated at least 5 days after L-NNA administration to ensure complete recovery from prior NO formation blockade. Vascular tolerance to NTG was achieved by skin application of three 0.8-mg NTG patches (Nitro-Dur, Schering) that were replaced every 12 h over 7 days. We have determined in five dogs that the method of NTG delivery mimicked the effects of systemic administration of NTG (2.0 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ). To confirm vascular tolerance, CBF responses to NTG boluses were assessed 3 and 7 days after the beginning of continuous NTG delivery. On these days, the exercise protocol was performed at least 2 h after boluses of NTG. NTG patches were removed after 7 days of continuous application. Seven days later, CBF responses to boluses of NTG were assessed, and the exercise protocol was performed before and after L-NNA administration.
At necropsy, the size of the circumflex artery perfusion bed was measured by using a dye perfusion method, and the cross-sectional area of the artery under the Doppler probe was determined. Therefore, data for CBF and MV O2 could be reported per gram of tissue.
Data analysis. Data are reported as means Ϯ SE under steady-state conditions during exercise. Responses to boluses of NTG were read at peak CBF before any apparent changes in MAP or HR. Blood O 2 content was calculated by the following equation: [Hb] (in g/dl) ϫ %Hb O 2 saturation ϫ 1.34 ml O2/g. MV O2 is the difference between aorta and CS O2 content times CBF (in l ⅐ min Ϫ1 ⅐ g of tissue Ϫ1 ). Oxygen delivery (Del O2) is the product of aortic blood O2 content and CBF. Triple product (TP) is the result of LVP ϫ LV dP/dt ϫ HR. (Fig. 2) . Therefore, O 2 supply and demand balance was maintained during NTG. NTG delivered through patches (after 4 h) also caused a shift of MV O 2 -TP relations, similar to that produced by intravenous NTG.
Conceivably, the decrease in MV O 2 caused by NTG involves NO, as an essential intermediate. In that eventuality, NTG should mimic the effects of endogenous NO, thereby reversing the effects of blockade of NO formation on cardiac MV O 2 . Therefore, NTG was administered during exercise performed after the blockade of endogenous NO formation with L-NNA. Blockade of NO formation dramatically increased the slope of the MV O 2 -TP relations as expected ( Fig. 1 and Table 2 ). Despite a smaller increase in TP during exercise performed after L-NNA, MV O 2 increased more. These effects of L-NNA on MV O 2 were reversed by NTG ( Fig. 1 and Table 2 ). Thus NTG acted as a surrogate of endogenous NO after its suppression by L-NNA.
Chronic vascular effects of NTG. The effects of systemic boluses of NTG on CBF responses are reported in Fig. 3 . Three and seven days of continuous NTG delivery dramatically reduced CBF responses to systemic boluses of NTG. When reported as percent changes from baseline, CBF responses were also substantially impaired. Seven days after NTG withdrawal, CBF responses to boluses of NTG had returned close to pretolerance levels.
Continuous NTG delivery was accompanied by reductions in LVP and MAP during exercise, whereas LVEDP, LV dP/dt, HR, and TP did not statistically differ from control responses (Table 3) . When compared with control, MV O 2 -TP relations had similar slopes but were shifted downward by NTG at 3 and 7 days of NTG delivery (Fig. 4) . These sustained effects of chronic NTG exposure on the MV O 2 -TP relations were quantitatively similar to those observed during acute NTG delivery. Thus chronic NTG delivery caused sustained reductions in MV O 2 for any given level of TP. In contrast to vascular responses, tolerance was not apparent on the metabolic effect of NTG.
Seven days after NTG withdrawal, MV O 2 -TP relations were back to pre-NTG values (Fig. 5) . At that time, blockade of NO formation failed to increase the slope of the MV O 2 -TP relations during exercise in contrast to responses before chronic NTG exposure ( Fig. 5 and (24) . The loss of NTG effects on LVEDP is consistent with the development of venous tolerance to NTG along with an increase in vascular volume (8, 19, 23) . Therefore, a distinct mechanism has to be invoked to account for the shift in the MV O 2 -TP relations caused by NTG.
NO, presumably the key intermediate in NTG effects, most likely accounts for the reductions in MV O 2 caused by NTG. In that connection, NO-dependent dilators, such as carbachol and bradykinin, caused a L-NNA-sensitive reduction in cardiac O 2 consumption in vitro, lost in transgenic eNOSϪ/Ϫ mice (9, 17, 18, 33) . Interestingly enough, S-nitroso-N-acetyl-penicillamine, a spontaneous NO donor, and NTG also decreased MV O 2 (9, 17, 33) . Renal and skeletal muscles O 2 consumption also displays a NO-dependent sensitivity (2, 27) . Conversely, blockade of NO formation in exercising dogs caused a disproportionate rise in cardiac MV O 2 , consistent with a modulatory influence of NO on O 2 consumption (3). In the present experiments, the effects of L-NNA on cardiac MV O 2 were reversed by NTG, as expected, if NTG effects involved NO production. Although functional and circumstantial evidence strongly support the concept that NTG-derived NO accounts for the O 2 -sparing effect of NTG, NO production in isolated vessels was only detected when doses of NTG exceeded therapeutic range (13) .
The main target of NO to decrease MV O 2 is probably the cytochrome-c oxidase, the terminal complex of the mitochondrial respiratory chain. NO competes with O 2 for binding the heme group of the cytochrome-c oxidase, thereby inhibiting mitochondrial respiration (30) .
In the present study, our method of NTG delivery was designed to trigger vascular tolerance. In agreement with this objective, CBF responses to boluses of NTG after 3 and 7 days of continuous NTG delivery were severely impaired. Given that Ͼ80% of the resistance of the coronary bed resides in vessels Ͻ200 m, CBF responses to NTG are deemed to reflect resistance vessel dilation (5) . Although vascular tolerance to organic nitrates has been mainly associated with conductance coronary vessels, the present study extends these findings to resistance coronary vessels.
Several mechanisms are currently considered pivotal to account for the time-dependent loss of sensitivity to NTG in conductance vessels. According to the mechanism-based hypothesis, tolerance is the expression of a downregulation of a key protein involved in the biotransformation of NTG to NO (4, 28) . Mitochondrial aldehyde dehydrogenase, which is downregulated in NTG-tolerant tissue, could be responsible for NO 2 Ϫ production from NTG that is locally converted to NO (29) . The NO availability hypothesis indicates that vascular tolerance leads to the production of oxygen-derived free radicals, which scavenge NTG-derived NO (10, 15, 20, 22) . A dysfunctional eNOS (21) and an augmented activity of the NAD(P)H oxidase (10, 20) account for an increased oxygen free radicals production in the setting of vascular tolerance. As a consequence of the limited bioavailability of NO, endothelium-and NO-dependent responses are compromised (10, 21, 26, 31) . The prevention of NTG tolerance and the improvement of endothelial dysfunction with antioxidant agents argue for the oxygen-derived free radical hypothesis (10, 11, 20, 32) . Presumably, the same mechanisms accounting for the development of tolerance in conductance vessel intervene in resistance vessels.
Recovery from tolerance was apparent 7 days after NTG withdrawal as CBF responses to boluses of NTG were restored. At that time, MV O 2 -TP relations were back to pre-NTG levels, but paradoxically the blockade of NO formation with L-NNA The consequences of NTG exposure differ in vascular and myocardial tissue. Metabolic effects (decreased O 2 consumption) of NTG were spared from tolerance in contrast to vascular responses. A marked decrease in vascular NO bioavailability occurs in the setting of tolerance as a consequence of increased oxidative stress (21) . In contrast, NTG fails to increase the O 2 free-radical burden in myocardial tissue when vascular tolerance occurs (6) . NTG-induced NO availability is even increased in the myocardium from animals with vascular tolerance to NTG (6) . This may explain why NTG caused sustained decreases in cardiac MV O 2 despite vascular tolerance. Apparently, the development of tolerance primarily targets cGMPdependent effects of NTG, such as vascular relaxation, and do not extend to cGMP-independent responses such as O 2 -sparing effects.
A (14) . By comparison, conductance coronary arteries are nearly 40 times more sensitive to the dilator action of NTG, making them a primary therapeutic target (34) . Together with the development of tolerance, these observations argue against the involvement of resistance coronary vessels in the reduction of MV O 2 caused by NTG.
In conclusion, acute NTG delivery reduces cardiac MV O 2 and reverses the disproportionate rise in MV O 2 caused by the blockade of endogenous NO formation during exercise. Despite vascular tolerance in the coronary microcirculation secondary to continuous NTG delivery, a sustained reduction of cardiac MV O 2 , independent of metabolic demand, was observed during exercise. NTG withdrawal reversed vascular tolerance and restored MV O 2 -TP relations during exercise. In contrast, blockade of endogenous NO formation failed to augment MV O 2 during exercise, consistent with an impaired NO-dependent modulation of O 2 consumption.
